Fig. 1 · Structure

Documents & Downloads

Quercetin dihydrate (Sophoretin)

Cat. No. A10765 CAS 6151-25-3

MAO-B inhibitor

Quercetin inhibits many enzyme systems including tyrosine protein kinase, phospholipase A2, phosphodiesterases, mitochondrial ATPase, PI 3-kinase and protein kinase C.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
PI3Kγ IC50 2.4 μM
PI3Kβ IC50 5.4 μM
PI3Kδ IC50 3.0 μM

Quercetin dihydrate (Sophoretin) Research Summary

This section summarizes 3 in vitro studies and 1 in vivo study of Quercetin dihydrate (Sophoretin) from 3 published references. In vitro models include MDCK cells; IMG.

Quercetin dihydrate (Sophoretin) In Vitro Studies

Quercetin produced no significant cytotoxicity in MDCK cells at 250 µg/mL after 48 h. In IMG, Quercetin concentration-dependently upregulated expression of the M2-polarized marker IL-10. In Nalm6 cells, the estimated Quercetin IC50 was 20 μM at 48 h. [1,2,3]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Quercetin Cytotoxicity in MDCK Cells

Cell-based study · MDCK cells [1]

MDCK cells received Quercetin at 250 µg/mL for 48 h. No significant cytotoxicity was observed.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cytotoxicityReported result no significant cytotoxicity[1]

Literature-Reported Treatment Conditions

Treatment concentration
250 µg/mL
Exposure duration
48 h
Method
fresh medium containing serially diluted compounds
Reported limits
Not stated in the sentences used: vehicle, control.
Methods and source locations

Compound reported in the paper: Quercetin

The paper names Quercetin without stating the salt or form; not verified as the dihydrate form supplied as A10765. No dose conversion or lot validation.

2. Result > 2.5. Quercetin Inhibited Entry of H5N1 Virus with Divergent Strains (S54); 4. Materials and Methods > 4.11. Cytotoxicity Test (S120, S122, S123)

cytotoxicity: cytotoxicity — 2. Result > 2.5. Quercetin Inhibited Entry of H5N1 Virus with Divergent Strains (S54); 4. Materials and Methods > 4.11. Cytotoxicity Test (S120)

Quercetin and Marker Expression in IMG

Cell-based study · IMG [2]

IMG received Quercetin stimulation for 6 h. Quercetin concentration-dependently upregulated expression of the M2-polarized marker IL-10.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
The mRNA levels IL-10 were analyzed by real-time PCR and normalized to β-actin.Reported result the stimulation of the quercetin concentration-dependently upregulated the expression of the M2-polarized marker IL-10 in both the macrophages (Figure 8A) and microglial cells (Figure 8B)[2]

Literature-Reported Treatment Conditions

Treatment concentration
1, 5, or 10 μM
Exposure duration
for 6 h
Method
stimulated with various concentrations of quercetin
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Quercetin

The paper names Quercetin without stating the salt or form; not verified as the dihydrate form supplied as A10765. No dose conversion or lot validation.

3. Results > 3.4. Quercetin Upregulates M2 Polarization and Endogenous Antioxidant Expression via the AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways (S65); Figure 8 legend (S112, S113, S115)

The mRNA levels IL-10 were analyzed by real-time PCR and normalized to β-actin.: The mRNA levels IL-10 were analyzed by real-time PCR and normalized to β-actin.; comparator: control group — 3. Results > 3.4. Quercetin Upregulates M2 Polarization and Endogenous Antioxidant Expression via the AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways (S65); Figure 8 legend (S113)

Quercetin and Cell Viability in Nalm6

Cell-based study · Nalm6 [3]

Nalm6 cells received Quercetin, with DMSO-treated cells as the control. The estimated Quercetin IC50 was 20 μM at 48 h.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cell viabilityIC50 20 μM[3]

Literature-Reported Treatment Conditions

Treatment concentration
10, 50, 100 and 250 μM
Exposure duration
48 h
Vehicle
DMSO
Reported limits
Not stated in the sentences used: route.
Methods and source locations

Compound reported in the paper: Quercetin

The paper names Quercetin without stating the salt or form; not verified as the dihydrate form supplied as A10765. No dose conversion or lot validation.

Results > Quercetin induces cytotoxicity in cancer cells (S5); Materials and Methods > Trypan blue exclusion assay (S79, S80, S81)

cell viability: cell viability; comparator: DMSO treated cells — Results > Quercetin induces cytotoxicity in cancer cells (S5); Materials and Methods > Trypan blue exclusion assay (S79)

Quercetin dihydrate (Sophoretin) In Vivo Studies

Quercetin was evaluated at 1 mg/kg in female Swiss albino mice bearing tumors. Compared with untreated control mice, Quercetin treatment increased life span by ~5 fold in at least 40% of mice. [3]

Quercetin and Life Span in Tumor-Bearing Mice

Animal study · female Swiss albino mice; Five animals bearing tumor were taken in each control and quercetin treated groups [3]

Female Swiss albino mice bearing tumors received Quercetin at 1 mg/kg. Compared with untreated control mice, Quercetin treatment increased life span by ~5 fold in at least 40% of mice.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
life spanlife span ~5 fold increase in the life span for atleast 40% of mice[3]

Conditions shared by the study groups

Treatment course
six doses; monitored for at least 250 days
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Quercetin 1 mg/kguntreated control miceWhile untreated control mice survived for a maximum of only ~50 days, treatment with quercetin led to a ~5 fold increase in the life span for atleast 40% of mice[3]
Quercetin 1 mg/kg
Model: female Swiss albino mice; Five animals bearing tumor were taken in each control and quercetin treated groups
Reported limits: Not stated in the sentences used: route, vehicle.
Methods and source locations

Compound reported in the paper: Quercetin

The paper names Quercetin without stating the salt or form; not verified as the dihydrate form supplied as A10765. No dose conversion or lot validation.

Results > Administration of quercetin improves the lifespan of tumor bearing mice, with no side effects (S33); Materials and Methods > Preparation of EAC cells and tumor induction (S104); Materials and Methods > Determination of effect of quercetin on survival of tumor animals (S115, S118); Figure 4 legend (S167); Figure 5 legend (S173)

life span: life span; comparator: untreated control mice — Results > Administration of quercetin improves the lifespan of tumor bearing mice, with no side effects (S33)

Quercetin 1 mg/kg · Results > Administration of quercetin improves the lifespan of tumor bearing mice, with no side effects (S33); Materials and Methods > Determination of effect of quercetin on survival of tumor animals (S118); Figure 5 legend (S173)

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 6151-25-3
Applications MAO-B inhibitor
Formula C15H10O7.2H2O
Molecular Weight 338.3
Synonyms Sophoretin; Meletin; Quercetine; Xanthaurine; Quercetol; Quercitin
SMILES
C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O.O.O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 58 mg/mL (171.45 mM)
Water Insoluble
Ethanol 18 mg/mL (53.21 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Quercetin dihydrate (Sophoretin) Research References

  1. [1] Wu W, Li R, Li X, et al. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry. Viruses (2015). PMID: 26712783 DOI: 10.3390/v8010006 Source material
  2. [2] Tsai CF, Chen GW, Chen YC, et al. Regulatory Effects of Quercetin on M1/M2 Macrophage Polarization and Oxidative/Antioxidative Balance. Nutrients (2021). PMID: 35010945 DOI: 10.3390/nu14010067 Source material
  3. [3] Srivastava S, Somasagara RR, Hegde M, et al. Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis. Sci Rep (2016). PMID: 27068577 DOI: 10.1038/srep24049 Source material

Added to your cart

View Cart Checkout
Loading...